Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by trial titles, indicators and specific disease types.

Hematologic

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

PNH Registry (M07-001)

  • Details

ClinicalTrials.gov ID: NCT01374360
Diagnosis Type: NA
USOR Number: 08160

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, CO 80228
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Webster

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy (NSABP B-51 / RTOG 1304)

  • Details

ClinicalTrials.gov ID: NCT01872975
Diagnosis Type: NA
USOR Number: 13091

  • Practice Details

501 Medical Center Blvd
Webster, TX 77598
P: (281) 332-7505

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Bethesda

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

6420 Rockledge Dr, Suite 4200
Bethesda, MD 20817
P: (301) 929-0765

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Clinton

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

8926 Woodyard Rd, Suite 101
Clinton, MD 20735
P: (301) 868-7911

More Details View Practice Page

Lymphomas

Clinical Trial at: Hematology Oncology Associates - Grants Pass

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

1879 Williams Hwy
Grants Pass, OR 97527
P: (888) 774-4911

More Details View Practice Page

Lymphomas

Clinical Trial at: Hematology Oncology Associates - Medford

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

2828 E Barnett Rd
Medford, OR 97504
P: (888) 774-4911

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Rockville

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

9905 Medical Center Dr, Suite 200
Rockville, MD 20850
P: (301) 424-6231

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Silver Spring

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

12210 Plum Orchard Dr, Suite 211
Silver Spring, MD 20904
P: (301) 933-3216

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Silver Spring

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

2730 University W Blvd, Suite 400
Silver Spring, MD 20902
P: (301) 942-9220

More Details View Practice Page

Liver Cancer

Clinical Trial at: Texas Oncology - Fort Worth

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

1001 12th Ave, Suite 200
Fort Worth, TX 76104
P: (817) 850-2000

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Parker

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

9397 Crown Crest Blvd, Suite 421
Parker, CO 80138
P: (303) 805-7744

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Plano

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

3705 West 15th Street
Plano, TX 75075
P: (972) 867-3577

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Plano

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, TX 75093
P: (972) 596-7801

More Details View Practice Page

Lymphomas

Clinical Trial at: Compass Oncology - Portland

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

9555 SW Barnes Rd, Suite 150
Portland, OR 97225
P: (503) 297-7403

More Details View Practice Page

Lymphomas

Clinical Trial at: Compass Oncology - Portland

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

265 North Broadway
Portland, OR 97227
P: (503) 280-1223

More Details View Practice Page

Lymphomas

Clinical Trial at: Compass Oncology - Portland

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

5050 NE Hoyt St, Suite 256
Portland, OR 97213
P: (503) 239-7767

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Pueblo

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

3676 Parker Blvd, Suite 350
Pueblo, CO 81008
P: (719) 296-6000

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Rockville

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

9905 Medical Center Dr, Suite 200
Rockville, MD 20850
P: (301) 424-6231

More Details View Practice Page

Pages